Rising Pharmaceuticals
Lisa Matthews has a diverse work experience spanning over multiple companies. Lisa worked at Rising Pharmaceuticals, Inc. from 2015, where they held the positions of Partnership Analytics & Reporting and Generic Pricing Manager. Prior to that, Lisa worked at H. D. Smith from 2013 to 2014 as the Manager of Generic Procurement Analytics, where they were responsible for financial analytics of the generic pharmaceutical business. Lisa also worked at Express Scripts (formerly Medco Health Solutions, Inc.) from 1997 to 2013 as the Director of Finance for Formulary Strategies and Solutions. In this role, they had an in-depth knowledge of the PBM industry and was responsible for generic forecasting and operating plan reporting. Lisa also identified and measured opportunities for improved margins within managed care programs.
Lisa Matthews has a Bachelor of Science degree in Accounting from Fairleigh Dickinson University. Lisa also holds a certification as a Certified Public Accountant from the State of New Jersey. The exact years of obtaining the degree and certification are not provided.
This person is not in any offices
Rising Pharmaceuticals
Rising Pharma Holdings, INC is an industry leader in marketing and distributing innovative branded and multi-source prescription and over-the-counter pharmaceutical products. Our many commercial products cross a variety of therapeutic areas and multiple dosage forms. We have a robust emerging pipeline of pharmaceutical products through the development of Abbreviated New Drug Applications (ANDA) filed,or in the process of being filed,with the FDA. Rising is committed to providing our customers with high quality pharmaceuticals. Our products are manufactured in state-of-the-art, FDA approved facilities using quality assurance techniques that meet regulatory standards. Through our close partnerships with our customers throughout the United States, we ensure the safe and effective delivery of our products to the public. Our leading management team of industry experts is dedicated towards continued innovation in drug development, marketing and distribution.